Search - tctmd.com

Displaying 301 - 320 of 1207

Sort: Relevancy | Date

News Daily News

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

Shelley Wood

May 06, 2020

News Conference News ACC 2020

LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout

Todd Neale

April 06, 2020

News Conference News ACC 2020

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Michael O'Riordan

March 29, 2020

News Daily News

Inclisiran Data in NEJM Prompt Talk of What Comes Next

Caitlin E. Cox

March 24, 2020

News Daily News

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

Shelley Wood

March 10, 2020

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for February 2020

Shelley Wood

March 02, 2020

News Conference News CRT 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

Michael O'Riordan

February 28, 2020

News Daily News

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

Shelley Wood

February 26, 2020

News Daily News

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

Shelley Wood

February 14, 2020

News Daily News

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Todd Neale

February 10, 2020

News Daily News

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

Caitlin E. Cox

February 07, 2020

News Daily News

European Regulators Approve First Transcatheter MV Replacement Device

Michael O'Riordan

January 30, 2020

News Conference News STS 2020

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

Yael L. Maxwell

January 29, 2020

News Conference News ISET 2020

FDA’s First Take on New Paclitaxel Concerns in CLI

Caitlin E. Cox

January 24, 2020

News Conference News ISET 2020

Venous Stents: Long-term Follow-up Plus a New Contender

Caitlin E. Cox

January 24, 2020

News Daily News

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

Shelley Wood

January 24, 2020

News Daily News

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

Michael O'Riordan

January 17, 2020

News Features

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

Michael O'Riordan

January 10, 2020

News Daily News

FDA Approves Two Generic Versions of Apixaban

Todd Neale

December 23, 2019

News Features

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Shelley Wood

December 23, 2019

Advertisement

FDA Clears Dapagliflozin for Heart Failure With Reduced Ejection Fraction

LAAO Registry: Safety of Watchman Looks Good in First Years of Rollout

Early Data Support TAVR in Bicuspid Valves, but Questions Remain

Inclisiran Data in NEJM Prompt Talk of What Comes Next

LEADER Analysis Reassures on Liraglutide in Diabetic Patients With Heart Failure

TCTMD’s Top 10 Most Popular Stories for February 2020

Newer, Thinner-Strut Abbott Scaffold Prompts Talk of a BVS Comeback

FDA Approves New Lipid-Lowering Drug, Bempedoic Acid

FDA: Obesity Drug Lorcaserin Exits US Market Over Cancer Concerns

Trials of New Cancer Drugs Failing to Address Potential CV Risks

Patient-Level Data Strengthen Rosiglitazone-CV Link: Meta-analysis

European Regulators Approve First Transcatheter MV Replacement Device

TAVR Tussle at US Surgery Meeting Threatens to Widen Surgeon-Cardiologist Wedge

FDA’s First Take on New Paclitaxel Concerns in CLI

Venous Stents: Long-term Follow-up Plus a New Contender

MitraClip in the US: As Coverage Update Looms, Some Questions for REPAIR MR

Injectable GLP-1 Agonist Semaglutide Gets CVD Event Reduction Indication

‘Outrageous’ $225,000 per Year List Price for Tafamidis Draws Outcry

FDA Approves Two Generic Versions of Apixaban

Year in Review: DAPA-HF Tops Heart Failure News Amid Other Wins and Losses

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content